Dietary manipulation, ethnicity, and serum PSA levels

Urology

Volumn 62, Issue 4, 2003, Pages 677-682

  Eastham, James A ^a   Riedel, Elyn ^b   Latkany, Lianne ^b   Fleisher, Martin ^b   Schatzkin, Arthur ^b   Lanza, Elaine ^b   Shike, Moshe ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER INCIDENCE; CAUCASIAN; CLINICAL TRIAL; COMPARATIVE STUDY; DIET; ETHNIC DIFFERENCE; ETHNOLOGY; EVALUATION; FAT INTAKE; FRUIT; HIGH FIBER DIET; HUMAN; LOW FAT DIET; MALE; MORTALITY; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; VEGETABLE; VEGETARIAN DIET;

EID: 0141784088     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00576-4     Document Type: Article

References (28)

1. Greenlee R.T., Murray T., Bolden S., et al. Cancer statistics, 2000. CA Cancer J Clin. 50:2000;7-33.
2. Morton R.A. Jr. Racial differences in adenocarcinoma of the prostate in North America. Urology. 44:1994;637-645.
3. Kolonel L.N. Racial and geographic variations in prostate cancer and the effect of migration. Fortner J.G., Sharp P.A. Accomplishments in Cancer Research, 1996. 1997;221-230 Lippincott-Raven, Philadelphia.
4. Kolonel L.N., Nomora A., Cooney R.V. Dietary fat and prostate cancer current status . J Natl Cancer Inst. 91:1999;414-428.
5. Lee M.M., Wang R.T., Hsing A.W., et al. Case-control study of diet and prostate cancer in China. Cancer Causes Control. 9:1998;545-552.
6. Whittemore A.S., Kolonel L.N., Wu A., et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 87:1995;652-661.
7. Platz E.A., Rimm E.B., Willet W.C., et al. Racial variation in prostate cancer incidence and hormonal system markers among male health professionals. J Natl Cancer Inst. 92:2000;2009-2017.
8. Stephenson R.A. Prostate cancer trends in the era of prostate-specific antigen an update of incidence, mortality, and clinical factors from the SEER database . Urol Clin North Am. 29:2002;173-181.
9. Robbins A.S., Whittemore A.S., Van Den Eeden S.K. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 90:1998;986-990.
10. Powell I.J., Schwartz K., Hussain M. Removal of the financial barrier to health care does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system . Urology. 46:1995;825-830.
11. Smith J.R., Freije D., Caupter J.D., et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 274:1996;1371-1374.
12. Irvine R.A., Yu M.C., Ross R.K., et al. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res. 55:1995;1937-1940.
13. Carter H.B., Pearson J.D., Metter E.J., et al. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate. 27:1995;25-31.
14. Kubricht W.S., Williams B.J., Whatley T., et al. Serum testosterone levels in African-American and white men undergoing prostate biopsy. Urology. 54:1999;1035-1038.
15. Rose D.P., Boyar A.P., Wyder E.L. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 58:1986;2363-2371.
16. Giovannucci E., Rimm E.D., Colditzm G.A., et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 85:1993;571-579.
17. Eastham J.A., May R.A., Whatley T., et al. Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer. J Natl Cancer Inst. 90:1998;756-760.
18. Bozeman C., Williams B.J., Whatley T., et al. Clinical and biopsy specimen features in black and white men with clinically localized prostate cancer. South Med J. 93:2000;400-402.
19. Powell I.J., Heilbrun L.K., Sakr W.D., et al. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer a multivariate analysis of positive surgical margins . Urology. 49:1997;726-731.
20. Schatzkin A., Lanza E., Freedman L.S., et al. The Polyp Prevention Trial. I Rationale, design, recruitment and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev. 5:1996;375-383.
21. Lanza E., Schatzkin A., Ballard-Barbash R., et al. The Polyp Prevention Trial. II. Dietary intervention and baseline participant dietary characteristics. Cancer Epidemiol Biomarkers Prev. 5:1996;385-392.
22. Schatzkin A., Lanza E., Corle D., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med. 342:2000;1149-1155.
23. Shike M., Latkany L., Riedel E., et al. Lack of effect of a low fat, high fruits, vegetables, and fiber diet on serum prostate specific antigen (PSA) of men without prostate cancer results from a randomized trial . J Clin Oncol. 20:2002;3592-3598.
24. Herbert J.R., Hurley T.G., Olendzki B.C., et al. Nutritional and socioeconomic factors in relation to prostate cancer mortality a cross-national study . J Natl Cancer Inst. 90:1998;1637-1647.
25. Wang Y., Corr C.G., Thale H.T., et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst. 87:1995;1456-1462.
26. von Holtz R.L., Fink C.S., Awad A.B. beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer. 32:1998;8-12.
27. Schuurman A.G., van den Brandt P.A., Dorant E., et al. Association of energy and fat intake with prostate carcinoma risk. Cancer. 86:1999;1019-1027.
28. Moyad M.A. Dietary fat reduction to reduce prostate cancer risk controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture . Urology. 59:2002;51-62.